Our attorneys have experience representing a number of novel therapeutics including:
  • antisense cancer therapies
  • benzodiazepines for cancer and autoimmune diseases
  • cancer vaccines
  • fatty acid based Alzheimer and stroke treatment
  • functional food products for diabetes
  • hemoglobin modulators for ischemia
  • interstitial cystitis treatment
  • islet cell growth factors
  • natural product based cancer therapeutics
  • novel nitrates for treatment of erectile dysfunction
  • novel paclitaxel derivatives and formulations
  • retroviral vectors for gene therapy
  • surfactant based anti-infective drugs
  • therapeutics for epilepsy and drug addiction